Goldman Sachs Maintains Buy on Freshpet, Lowers Price Target to $120
Goldman Sachs maintains Freshpet (NASDAQ:FRPT) with a Buy and lowers the price target from $136 to $120.
Analyst Ratings for Freshpet
Over the past 3 months, 5 analysts have published their opinion on Freshpet (NASDAQ:FRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Why These Beyond Meat Analysts Are Barbecuing Price Targets After $100M Q1 Loss: ‘Lower Likelihood Of Disruption’
Beyond Meat Inc (NASDAQ: BYND) shares traded higher Thursday before moving lower in the afternoon, and remain down 56.6% year-to-date after the company reported a larger-than-expected first-quarter net lo
Freshpet Raises $350M Via Equity Offering
Freshpet Inc (NASDAQ:FRPT) has priced the follow-on offering of 4.3 million shares at $81 per share. The offer price represents a…
Freshpet Priced ~4.32M Share Public Offering of Common Stock @$81/Share
Freshpet, Inc. ("Freshpet") (NASDAQ: FRPT) today announced the pricing of its follow-on offering of 4,320,988 shares of its common stock in an underwritten public offering at a price to the public of $81.00 per share.
Preview: Freshpet’s Earnings
Freshpet (NASDAQ:FRPT) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement.
Analysts estimate that Freshpet will report an earnings per share (EPS) of $-0.39.
Goldman Sachs Upgrades Freshpet to Buy, Raises Price Target to $136
Goldman Sachs analyst Jason English upgrades Freshpet (NASDAQ:FRPT) from Neutral to Buy and raises the price target from $111 to $136.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.